We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
Cap. Flow
+$2.89B
Cap. Flow %
1.9%
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 8.61%
3 Healthcare 7.69%
4 Industrials 6.49%
5 Consumer Discretionary 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBT
3276
Permian Basin Royalty Trust
PBT
$1.52B
$351K ﹤0.01%
31,163
-3,806
-11% -$46.2K
VERX icon
3277
Vertex
VERX
$1.98B
$350K ﹤0.01%
9,713
-355
-4% -$11.4K
HNW
3278
DELISTED
Pioneer Diversified High Income Fund
HNW
$348K ﹤0.01%
29,835
+2,326
+8% +$27K
NWBI icon
3279
Northwest Bancshares
NWBI
$2.29B
$348K ﹤0.01%
30,097
-8,718
-22% -$95.8K
INSP icon
3280
Inspire Medical Systems
INSP
$1.71B
$348K ﹤0.01%
2,597
+1,494
+135% +$283K
IIM icon
3281
Invesco Value Municipal Income Trust
IIM
$595M
$347K ﹤0.01%
28,152
+16,729
+146% +$197K
VCEB icon
3282
Vanguard ESG US Corporate Bond ETF
VCEB
$1.15B
$347K ﹤0.01%
5,585
ZIP icon
3283
ZipRecruiter
ZIP
$405M
$347K ﹤0.01%
38,130
-2,738
-7% -$27.6K
DJT icon
3284
Trump Media & Technology Group
DJT
$2.48B
$346K ﹤0.01%
10,551
-2,647
-20% -$111K
ESQ icon
3285
Esquire Financial Holdings
ESQ
$1.15B
$345K ﹤0.01%
7,256
+42
+0.6% +$1.97K
LCNB icon
3286
LCNB Corp
LCNB
$282M
$345K ﹤0.01%
24,826
+35
+0.1% +$502
GTLB icon
3287
GitLab
GTLB
$7.11B
$345K ﹤0.01%
6,944
-12,539
-64% -$652K
DFNL icon
3288
Davis Select Financial ETF
DFNL
$493M
$344K ﹤0.01%
10,372
-465
-4% -$15.3K
VIAV icon
3289
Viavi Solutions
VIAV
$9.47B
$344K ﹤0.01%
50,127
-1,822
-4% -$14.2K
CVY icon
3290
Invesco Zacks Multi-Asset Income ETF
CVY
$124M
$344K ﹤0.01%
13,724
-611
-4% -$15.5K
TBI
3291
Trueblue
TBI
$310M
$343K ﹤0.01%
+33,260
New +$360K
ALX
3292
Alexander's
ALX
$1.39B
$342K ﹤0.01%
1,522
+56
+4% +$12.1K
PCEF icon
3293
Invesco CEF Income Composite ETF
PCEF
$817M
$342K ﹤0.01%
18,166
-1,138
-6% -$21K
U icon
3294
Unity
U
$19.3B
$342K ﹤0.01%
21,006
-8,635
-29% -$185K
GFI icon
3295
Gold Fields
GFI
$36B
$341K ﹤0.01%
22,868
-3,900
-15% -$63.4K
PTIN icon
3296
Pacer Trendpilot International ETF
PTIN
$187M
$340K ﹤0.01%
11,769
-3,739
-24% -$108K
GRPN icon
3297
Groupon
GRPN
$889M
$340K ﹤0.01%
22,241
+6,504
+41% +$86.8K
EMM icon
3298
Global X Emerging Markets ex-China ETF
EMM
$55.8M
$340K ﹤0.01%
11,931
LEN.B icon
3299
Lennar Class B
LEN.B
$20.8B
$340K ﹤0.01%
2,564
+119
+5% +$16.3K
HELE icon
3300
Helen of Troy
HELE
$682M
$340K ﹤0.01%
3,663
+438
+14% +$44.4K

Similar funds

Raymond James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
  • Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
  • Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
  • Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
  • Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.